UNSPSC 85631734: Replacement of bilateral breast with nonautologous tissue substitute, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of bilateral breast with nonautologous tissue substitute, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HRVXKZ

UNSPSC 85631734 Replacement of bilateral breast with nonautologous tissue substitute, external approach is a Commodity code that does not align with state and local government procurement activity. The code nominally describes a specific surgical procedure — bilateral breast reconstruction using synthetic or donor tissue — but recent state and local opportunities posted under this code involve occupational medical surveillance, independent medical evaluation services, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-outs for employee health plans, and emergency medical services for youth in custody. None of these solicitations concern breast reconstruction implants, surgical supplies, or related orthopaedic devices. The mismatch suggests either systematic miscoding in the source data or a fundamental disconnect between the UNSPSC taxonomy and how these jurisdictions are tagging their medical services procurements.

No recent state and local opportunities specifically solicit breast reconstruction implants, synthetic tissue substitutes, or related surgical consumables under this code. The issuing bodies in the recent-opportunities block — the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and Santa Clara County Health System — are purchasing medical services, staffing, and administrative support, not implantable medical devices or surgical material. Without corroborating evidence that state and local procurement offices are actively buying bilateral breast reconstruction implants or nonautologous tissue substitutes under this code, the Commodity shows no actionable activity for vendors in the implant or surgical-supply space.